Sanatogen

Last updated

Sanatogen
Product type Patent medicine
OwnerBauer
Country Germany

Sanatogen was a "brain tonic" invented by the Bauer Chemical Company, in Germany in 1898 and sold worldwide [1]

Contents

In the US it was advertised as a "nerve revitaliser". The medicine was prohibited in Australia in 1915 during World War I and a British-made substitute "Sanagen" was introduced to the Australian market the following year, claiming to be "identical to Sanatogen". The product became fashionable in China in the early 20th century and won the favour of many renowned people. [1]

The indications or uses for this product provided by the manufacturer were: "Food tonic. A concentrated nutrient with tonic properties... easily digested and absorbed and is recommended as an effective means of reinforcing the daily diet of anaemic and convalescent patients." [2]

Product information

The ingredients have been described as:

Marketing

The product was marketed extensively in Europe and the US with such slogans as "Endorsed by over 20,000 Physicians". [3]

Court case

In 1913 the product was at the centre of a United States Supreme Court case: Bauer & Cie. v. O'Donnell . The product was also the subject of intellectual property litigation worldwide. [4]

Other products

The Sanatogen brand persists in the UK as a fortified wine, with an alcohol content of 15%. [5]

Sanatogen is also the name of a modern multivitamin product manufactured by Fisons before being sold to Roche, and later Bayer. [6]

Related Research Articles

<span class="mw-page-title-main">Gin</span> Distilled alcoholic drink flavoured with juniper

Gin is a distilled alcoholic drink that derives its flavour from juniper berries and other botanical ingredients.

<span class="mw-page-title-main">John Stith Pemberton</span> American pharmacist, inventor of Coca-Cola (1831–1888)

John Stith Pemberton was an American pharmacist and Confederate States Army veteran who is best known as the inventor of Coca-Cola. In May 1886, he developed an early version of a beverage that would later become Coca-Cola, but sold its rights to the drink shortly before his death in 1888.

<span class="mw-page-title-main">Tylenol (brand)</span> Medication

Tylenol is a brand of medication, advertised for reducing pain, reducing fever, and relieving the symptoms of allergies, cold, cough, headache, and influenza. The active ingredient of its original flagship product is paracetamol, an analgesic and antipyretic. Like the words paracetamol and acetaminophen, the brand name Tylenol is derived from a chemical name for the compound, N-acetyl-para-aminophenol (APAP). The brand name is owned by McNeil Consumer Healthcare, a subsidiary of Kenvue.

<span class="mw-page-title-main">Coca-Cola formula</span> Coca-Cola Companys recipe for Coca-Cola syrup

The Coca-Cola Company's formula for Coca-Cola syrup, which bottlers combine with carbonated water to create the company's flagship cola soft drink, is a closely guarded trade secret. Company founder Asa Candler initiated the veil of secrecy that surrounds the formula in 1891 as a publicity, marketing, and intellectual property protection strategy. While several recipes, each purporting to be the authentic formula, have been published, the company maintains that the actual formula remains a secret, known only to a very few select employees.

<span class="mw-page-title-main">Generic drug</span> Pharmaceutical equivalent to a brand-name product

A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.

<span class="mw-page-title-main">Patent medicine</span> Medicine sold regardless of effectiveness

A patent medicine is a non-prescription medicine or medicinal preparation that is typically protected and advertised by a trademark and trade name, and claimed to be effective against minor disorders and symptoms, as opposed to an ethical drug that could be obtained only through a pharmacist, usually with a doctor's prescription, and whose composition was openly disclosed. Many over-the-counter medicines were once ethical drugs obtainable only by prescription, and thus are not patent medicines.

<span class="mw-page-title-main">Energy drink</span> Beverage containing stimulants

An energy drink is a type of drink containing stimulant compounds, usually caffeine, which is marketed as providing mental and physical stimulation. They may or may not be carbonated and may also contain sugar, other sweeteners, herbal extracts, taurine, and amino acids. They are a subset of the larger group of energy products, which includes bars and gels, and distinct from sports drinks, which are advertised to enhance sports performance. There are many brands and varieties in this drink category.

Bauer & Cie. v. O'Donnell, 229 U.S. 1 (1913), was a 1913 United States Supreme Court decision involving whether a purchaser of a patented product bearing a price-fixing notice incurs guilt of patent infringement by reselling the product at a price lower than that which the notice commands. A divided Court (5–4) held that it was not.

<span class="mw-page-title-main">Benadryl</span> Brand of various antihistamine medications

Benadryl is a brand of various antihistamine medications used to stop allergies, whose content varies in different countries, but which includes some combination of diphenhydramine, acrivastine, and/or cetirizine.

<span class="mw-page-title-main">Sibutramine</span> Chemical compound used in the treatment of obesity in some countries

Sibutramine, formerly sold under the brand name Meridia among others, is an appetite suppressant which has been discontinued in many countries. It works as a serotonin–norepinephrine reuptake inhibitor similar to a tricyclic antidepressant. Until 2010, it was widely marketed and prescribed as an adjunct in the treatment of obesity along with diet and exercise. It has been associated with increased cardiovascular diseases and strokes and has been withdrawn from the market in 2010 in several countries and regions including Australia, Canada, China, the European Union, Hong Kong, India, Mexico, New Zealand, the Philippines, Thailand, the United Kingdom, and the United States. However, the drug remains available in some countries.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

<span class="mw-page-title-main">Yunnan Baiyao</span> Proprietary traditional Chinese medicine

Yunnan Baiyao is a proprietary traditional Chinese medicine marketed and used as a hemostatic product in both human and veterinary alternative medicine. Although Yunnan Baiyao has long been recognized as a pharmaceutical preparation in China, the safety and efficacy of Yunnan Baiyao has not been assessed or established by the FDA, the European Medicines Agency, or the Australian Therapeutic Goods Administration. There is limited evidence regarding its effectiveness in preventing and treating hemorrhagic and pathological conditions in both humans and animals via oral administration. In a limited number of human studies of small sample sizes, administration of Yunnan Baiyao has been shown to correlate with "reduced perioperative bleeding as well as bleeding in various ulcerative–hemorrhagic conditions". It has become popular particularly for animals with hemangiosarcoma. There are multiple routes of drug administration. Yunnan Baiyao is sold in powder, tincture, plaster, paste, aerosol, or tablet form. The medicine, developed by Qu Huangzhang in 1902, is designated as one of two Class-1 protected traditional Chinese medicines, which gives it 20 years of trade protection in China. Yunnan Baiyao products are manufactured and distributed by a state-owned enterprise, Yunnan Baiyao Group in Yunnan, China.

A counterfeit medication or a counterfeit drug is a medication or pharmaceutical item which is produced and sold with the intent to deceptively represent its origin, authenticity, or effectiveness. A counterfeit drug may contain inappropriate quantities of active ingredients, or none, may be improperly processed within the body, may contain ingredients that are not on the label, or may be supplied with inaccurate or fake packaging and labeling. Counterfeit drugs are related to pharma fraud. Drug manufacturers and distributors are increasingly investing in countermeasures, such as traceability and authentication technologies, to try to minimise the impact of counterfeit drugs. Antibiotics with insufficient quantities of an active ingredient add to the problem of antibiotic resistance.

Counterfeit consumer goods are goods, often of inferior quality, made or sold under another's brand name without the brand owner's authorization. Sellers of such goods may infringe on either the trademark, patent or copyright of the brand owner by passing off its goods as made by the brand owner. Counterfeit products made up 5 to 7% of world trade in 2013, and in 2014 cost an estimated 2.5 million jobs worldwide, with up to 750,000 jobs lost in the U.S. About 5% of goods imported into the European Union in 2013 were fakes, according to the OECD.

Teva API is an international pharmaceutical company headquartered in Israel. Teva API is a stand-alone business unit of Teva Pharmaceutical Industries limited, the largest generic drug manufacturer in the world and one of the 15 largest pharmaceutical companies worldwide.

<span class="mw-page-title-main">Aspen Pharmacare</span> Major pharmaceutical company in South Africa

Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange (JSE) in 1998 and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals (ARVs) and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union.

<span class="mw-page-title-main">Tiger bone wine</span> Alcoholic beverage originally produced in China using the bones of tigers

Tiger bone wine is an alcoholic beverage originally produced in China using the bones of tigers as a necessary ingredient. The production process takes approximately eight years and results in a high alcohol concentration. According to traditional Chinese medicine, the specific use of certain body parts is capable of healing diseases according to the characteristics of the animal used to obtain the product, that is believed to be connected with the disease of the person.

References

  1. 1 2 Pei-yin Lin and Weipin Tsai (eds) (2014), Print, Profit, and Perception: Ideas, Information and Knowledge in Chinese Societies, 1895-1949, Brill Academic Pub, ISBN   978-9004259102, pp.128-135
  2. 1 2 "Sanatogen | National Museum of American History". National Museum of American History . Smithsonian Institution . Retrieved 15 July 2020.
  3. Everybody's Magazine , Vol, XXXVVII, No. 5, May 1918, p.111,
  4. Banerjee, Arpan; Beldiman, Dana (23 October 2020). "International trade mark enforcement under the Versailles Treaty: a case study of Sanatogen". Forgotten Intellectual Property Lore.
  5. "Sanatogen Tonic Wine Original 70Cl" . Retrieved 24 September 2014.
  6. "Sanatogen" . Retrieved 24 September 2014.